Skip to content
REGISTER FOR FREE
buysidedigest hedge fund letters for investors
  • Investor Letters
  • BSD 13Fs
  • Elevator Pitches
  • BSDigest
  • Insights
  • Login
  • Register
  • Investor Letters
  • BSD 13Fs
  • Elevator Pitches
  • BSDigest
  • Insights
  • Login
  • Register

Pitch Keyword: prescription traction

Management Talks: Journey Medical — A Classic Execution Story in the MakingJourney Medical – DERM

Pitch Summary: Journey Medical is poised for growth with its new product, Emrosi, an oral treatment for rosacea that launched in April 2025. The company has a strong leadership team with experience from Medicis, and Emrosi is expected to generate significant revenue due to its early prescription traction and a robust commercial strategy. BSD Analysis: […]

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

join for free
buysidedigest hedge fund letters for investors
  • [email protected]

Follow Us On:

  • © 2025 Buyside Digest
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Terms of Service